Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes. by El-Jawhari, J, El-Sherbiny, Y, Scott, G, Morgan, R, Prestwich, R, Bowles, P, Blair, G, Tanaka, T, Rabbitts, T, Meade, J, Cook, G

Brief report: group 3 innate lymphoid cells in human enthesis by Cuthbert, R, Fragkakis, E, Dunsmuir, R, Li, Z, Coles, M, Marzo-Ortega, H, Giannoudis, P, Jones, E, El-Sherbiny, Y, McGonagle, D